berberine and astaxanthine

berberine has been researched along with astaxanthine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Cicero, AF; Rovati, LC; Setnikar, I1
Cacciotti, L; Caminiti, G; Grieco, F; Iaia, L; Marazzi, G; Massaro, R; Pelliccia, F; Rosano, G; Sposato, B; Volterrani, M1
Brea, A; De Castro-Orós, I; Mozas, P; Pocoví, M; Puzo, J; Solà, R; Valls, RM1
Andreozzi, S; Dalmaso, S; Fabrizio, A; Marchitto, N; Mauti, M; Raimondi, G; Sindona, F1
Bellentani, S; Cicero, AFG; Colletti, A1
Avila-Carrasco, L; Díaz-Avila, DL; García-Mayorga, EA; Garza-Veloz, I; González-Mateo, GT; Martinez-Fierro, ML1

Reviews

2 review(s) available for berberine and astaxanthine

ArticleYear
Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.
    Nutrients, 2018, Aug-23, Volume: 10, Issue:9

    Topics: Antioxidants; Berberine; Curcumin; Dietary Supplements; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Humans; Meta-Analysis as Topic; Non-alcoholic Fatty Liver Disease; Obesity; Observational Studies as Topic; Plant Extracts; Probiotics; Randomized Controlled Trials as Topic; Resveratrol; Salvia miltiorrhiza; Silymarin; Ubiquinone; Vitamin D; Vitamin E; Xanthophylls

2018
Potential Therapeutic Effects of Natural Plant Compounds in Kidney Disease.
    Molecules (Basel, Switzerland), 2021, Oct-09, Volume: 26, Issue:20

    Topics: Antioxidants; Berberine; Beta vulgaris; Betalains; Biological Products; Catechin; Curcumin; Disulfides; Flavonoids; Humans; Isothiocyanates; Kidney; Kidney Diseases; Plant Extracts; Pomegranate; Protective Agents; Resveratrol; Sulfinic Acids; Sulfoxides; Xanthophylls

2021

Trials

2 trial(s) available for berberine and astaxanthine

ArticleYear
Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation.
    Arzneimittel-Forschung, 2007, Volume: 57, Issue:1

    Topics: Anticholesteremic Agents; Berberine; Cholesterol; Dietary Supplements; Drug Combinations; Dyslipidemias; Fatty Alcohols; Female; Folic Acid; Humans; Lipids; Lipoproteins; Liver Function Tests; Male; Middle Aged; Single-Blind Method; Xanthophylls

2007
Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.
    Advances in therapy, 2011, Volume: 28, Issue:12

    Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Berberine; Biological Products; Blood Glucose; Cholesterol; Dietary Supplements; Fatty Alcohols; Female; Folic Acid; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Medication Adherence; Prospective Studies; Single-Blind Method; Ubiquinone; Xanthophylls

2011

Other Studies

2 other study(ies) available for berberine and astaxanthine

ArticleYear
Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine.
    PloS one, 2016, Volume: 11, Issue:3

    Topics: Adult; Aged; Alleles; Berberine; Cholesterol, LDL; Fatty Alcohols; Female; Heterozygote; Humans; Hypercholesterolemia; Linear Models; Male; Middle Aged; Polymorphism, Single Nucleotide; Proprotein Convertase 9; Proprotein Convertases; Receptors, LDL; Serine Endopeptidases; Xanthophylls

2016
Effect of new nutraceutical formulation with policosanol, berberine, red yeast rice, cassia nomame, astaxantine and Q10 coenzyme in patients with low-moderate dyslipidemia associated with intolerance to statins and metabolic syndrome.
    Minerva cardioangiologica, 2018, Volume: 66, Issue:1

    Topics: Berberine; Biological Products; Cassia; Dietary Supplements; Dyslipidemias; Fatty Alcohols; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metabolic Syndrome; Treatment Outcome; Ubiquinone; Xanthophylls

2018